What sector does Nykode Therapeutics ASA (NYKD) operate in?
Nykode Therapeutics ASA belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Nykode Therapeutics ASA (NYKD) current stock price?
As of the latest data, Nykode Therapeutics ASA stock price is NOK 2.95, with a previous close of NOK 2.95. Nykode Therapeutics ASA gained NOK 0.00 in the last trading session, representing a 0.14% increase.
What is Nykode Therapeutics ASA (NYKD) current market capitalization?
Nykode Therapeutics ASA market cap is approximately 964.62 million.
What is Nykode Therapeutics ASA (NYKD) Earnings Per Share (EPS)?
The trailing EPS is -NOK 0.39, and the forward EPS is -NOK 0.71.
Does Nykode Therapeutics ASA (NYKD) pay dividends?
Yes. Nykode Therapeutics ASA pays annual dividends with an annualized yield of 33.85% and an estimated annual payout of NOK 1.00 per share.
When is the next ex-dividend date for Nykode Therapeutics ASA (NYKD)?
The next ex-dividend date is scheduled for May 27, 2026.
When is Nykode Therapeutics ASA (NYKD) next earnings report?
Nykode Therapeutics ASA is expected to release its next earnings report on March 31, 2026.
What is Nykode Therapeutics ASA (NYKD) beta (volatility) score?
Nykode Therapeutics ASA has a beta of 1.174, meaning its volatility is roughly in line with the market.